{"id":18444,"date":"2020-03-10T16:38:37","date_gmt":"2020-03-10T15:38:37","guid":{"rendered":"https:\/\/www.satt.fr\/dianosic-obtient-le-marquage-ce\/"},"modified":"2020-03-10T16:58:57","modified_gmt":"2020-03-10T15:58:57","slug":"dianosic-obtient-le-marquage-ce","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/","title":{"rendered":"Conectus : Dianosic obtient le marquage CE"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-18435\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/DIANOSIC_logo.png\" alt=\"dianosic logo\" width=\"206\" height=\"220\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/DIANOSIC_logo.png 206w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/DIANOSIC_logo-140x150.png 140w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/DIANOSIC_logo-94x100.png 94w\" sizes=\"auto, (max-width: 206px) 100vw, 206px\" \/><strong>Dianosic, startup propuls\u00e9e par la SATT Conectus, obtient le marquage CE pour CAVI-TTM, son dispositif m\u00e9dical de traitement des saignements intranasaux. Cette \u00e9tape importante permettra \u00e0 Dianosic de lancer la commercialisation de sa solution mini-invasive en France et en Europe, et de poursuivre le d\u00e9veloppement d\u2019autres dispositifs innovants.<\/strong><\/p>\n<p>\nDianosic, start-up strasbourgeoise sp\u00e9cialis\u00e9e dans les solutions innovantes pour les pathologies ORL, annonce l\u2019obtention du marquage CE pour CAVI-TTM, un ballonnet asym\u00e9trique basse pression pour traiter les saignements spontan\u00e9s et postop\u00e9ratoires des fosses nasales.<\/p>\n<p>Cette certification de classe 2a obtenue fin f\u00e9vrier va permettre \u00e0 la soci\u00e9t\u00e9 d\u2019initier sa commercialisation en Europe. CAVI-TTM, destin\u00e9 au traitement des saignements intranasaux (\u00e9pistaxis), est couvert par un brevet valide pour la France et bient\u00f4t pour l\u2019Europe, les \u00c9tats-Unis, le Japon et la Chine.<\/p>\n<ul>\n<li>Il s\u2019agit du premier ballonnet intranasal de forme asym\u00e9trique qui assure l\u2019arr\u00eat du saignement, ou h\u00e9mostase, par compression \u00e0 basse pression tout en s&#8217;adaptant \u00e0l\u2019anatomie de la fosse nasale. Le ballonnet peut rester en place entre un et trois jours.<\/li>\n<li>Ce dispositif m\u00e9dical atraumatique, facile d\u2019utilisation, s\u2019adresse aujourd\u2019hui principalement aux \u00e9tablissements hospitaliers. Il a d\u00e9montr\u00e9 son efficacit\u00e9 et sa s\u00e9curit\u00e9 dans le cadre d\u2019une \u00e9tude pilote r\u00e9alis\u00e9e d\u2019avril \u00e0 juin 2019 sous la conduite du Pr. Christian Debry, chef du service d&#8217;ORL et de chirurgie cervico-faciale du CHU de Strasbourg.<\/li>\n<li>Le ballonnet a \u00e9t\u00e9 efficace pour arr\u00eater les saignements chez 90% des patients, tout en am\u00e9liorant significativement leur qualit\u00e9 de vie. Cette \u00e9tude pilote a \u00e9galement d\u00e9montr\u00e9 la bonne tol\u00e9rance du CAVI-TTM, avec un score moyen de douleur (\u00e9valu\u00e9 sur une \u00c9chelle Visuelle Analogique allant de 1 \u00e0 10) de respectivement 4,7 et 1,6 lors de l&#8217;insertion et du<br \/>\nretrait du produit.<\/li>\n<\/ul>\n<p><em>\u00ab L\u2019obtention du marquage CE est une vraie reconnaissance du savoir-faire de Dianosic et de son \u00e9quipe pour imaginer et mettre au point des produits innovants pour le traitement des affections ORL \u00bb<\/em>, d\u00e9clare Marc Augustin, Pr\u00e9sident de Dianosic.<\/p>\n<p>\n<em>\u00ab Gr\u00e2ce \u00e0 cette \u00e9tape majeure dans notre d\u00e9veloppement, nous allons pr\u00e9parer le lancement commercial du produit en Europe au cours du deuxi\u00e8me trimestre 2020. L&#8217;entr\u00e9e de Dianosic sur le march\u00e9 repr\u00e9sente une opportunit\u00e9 de croissance unique, avec la perspective de traiter pr\u00e8s de cinq millions de patients en Europe et aux \u00c9tats-Unis,<\/em> \u00bb souligne Philippe Bastide, CEO de Dianosic.<\/p>\n<h5>\n<strong>\u00c0 propos de Dianosic SAS<\/strong><br \/>\nDianosic d\u00e9veloppe des solutions innovantes pour la prise en charge des pathologies de la sph\u00e8re ORL. Incub\u00e9e par SEMIA, labellis\u00e9 incubateur d&#8217;excellence de la R\u00e9gion Grand Est depuis janvier 2018, la soci\u00e9t\u00e9 est anim\u00e9e par un duo compos\u00e9 de Marc Augustin, Pr\u00e9sident de la soci\u00e9t\u00e9 et Philippe Bastide, CEO. Le Pr. Christian Debry, chef du service ORL et du P\u00f4le t\u00eate et cou du CHU de Strasbourg, assure un r\u00f4le de conseiller scientifique. Dianosic est laur\u00e9ate du concours d\u2019innovation I-Lab 2019 organis\u00e9 par Bpifrance et a \u00e9t\u00e9 s\u00e9lectionn\u00e9e pour participer \u00e0 un programme de \u00ab soft landing \u00bb \u00e0 Boston (USA), organis\u00e9 en septembre 2019 par l\u2019Eurom\u00e9tropole de Strasbourg et Innouvo en partenariat avec Cajuba Finance.<br \/>\nCr\u00e9\u00e9e en juillet 2017 et bas\u00e9e \u00e0 Strasbourg, Dianosic a pour ambition de devenir un leader europ\u00e9en dans le domaine de la prise en charge des saignements intranasaux et de la sinusite chronique avec son traitement actif r\u00e9sorbable au long cours.<\/h5>\n<p><a href=\"https:\/\/dianosic.com\/\"><strong>www.dianosic.com<\/strong><\/a>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dianosic, startup propuls\u00e9e par la SATT Conectus, obtient le marquage CE pour CAVI-TTM, son dispositif m\u00e9dical de traitement des saignements intranasaux. Cette \u00e9tape importante permettra \u00e0 Dianosic de lancer la commercialisation de sa solution mini-invasive en France et en Europe, et de poursuivre le d\u00e9veloppement d\u2019autres dispositifs innovants. Dianosic, start-up strasbourgeoise sp\u00e9cialis\u00e9e dans les solutions [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":18446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568,604],"tags":[],"class_list":["post-18444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conectus : Dianosic obtient le marquage CE - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France MANDRY\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/\"},\"author\":{\"name\":\"France MANDRY\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"headline\":\"Conectus : Dianosic obtient le marquage CE\",\"datePublished\":\"2020-03-10T15:38:37+00:00\",\"dateModified\":\"2020-03-10T15:58:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/\"},\"wordCount\":594,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg\",\"articleSection\":[\"News\",\"Success Stories\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/\",\"url\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/\",\"name\":\"Conectus : Dianosic obtient le marquage CE - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg\",\"datePublished\":\"2020-03-10T15:38:37+00:00\",\"dateModified\":\"2020-03-10T15:58:57+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg\",\"width\":3200,\"height\":1785},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conectus : Dianosic obtient le marquage CE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\",\"name\":\"France MANDRY\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/france\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conectus : Dianosic obtient le marquage CE - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/","twitter_misc":{"Written by":"France MANDRY","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/"},"author":{"name":"France MANDRY","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"headline":"Conectus : Dianosic obtient le marquage CE","datePublished":"2020-03-10T15:38:37+00:00","dateModified":"2020-03-10T15:58:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/"},"wordCount":594,"image":{"@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg","articleSection":["News","Success Stories","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/","url":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/","name":"Conectus : Dianosic obtient le marquage CE - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg","datePublished":"2020-03-10T15:38:37+00:00","dateModified":"2020-03-10T15:58:57+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/03\/CND.jpg","width":3200,"height":1785},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/dianosic-obtient-le-marquage-ce\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Conectus : Dianosic obtient le marquage CE"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e","name":"France MANDRY","url":"https:\/\/www.satt.fr\/en\/author\/france\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/18444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=18444"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/18444\/revisions"}],"predecessor-version":[{"id":18447,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/18444\/revisions\/18447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/18446"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=18444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=18444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=18444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}